Author(s):
Chaitali K. Gunjal, Shashikant Barhate, Manoj Bari, Shaikh Samir
Email(s):
chaitaligunjal81@gmail.com
DOI:
10.52711/0975-4377.2024.00003
Address:
Chaitali K. Gunjal1*, Shashikant Barhate2, Manoj Bari3, Shaikh Samir4
1Shri Gulabrao Deokar Collage of Pharmacy, Jalgaon, Dist. Jalgaon.
2,3,4Shri Sureshdada Jain Institute of Pharmaceutical Education and Research, Jamner, Dist. Jalgaon.
*Corresponding Author
Published In:
Volume - 16,
Issue - 1,
Year - 2024
ABSTRACT:
The aim of present research was formulation development and evaluation of sustained release rectal suppository of domperidone maleate. By using Hot fusion method in that combination of PEG 4000 and poloxamer 188 was used as polymer and HPMC K4M was used for sustained released effect and surfactant was utilized for increasing bioavailability. The formulation was optimized based on Design expert software and Central Composite Design was used for study. Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) were performed to check any interaction between drug and excipients. The hardness, weight variation, friability, micro melting range test, disintegration time, dissolution studies and uniformity content of formulated batches were evaluated. All the results were within the acceptable pharmacopeial limits and were evaluated statistically by using one way ANOVA test for quadratic model. From the result, S7 batch was observed optimized formulation because upto 8 hrs 90.82% drug was released. kinetic studies of the drug release for optimized formulation follows zero order kinetics. This study was concluded that rectal route was more beneficial than oral route because it avoids first pass metabolism and enhance bioavailability of Domperidone maleate. The prepared Domperidone maleate suppository will be used for emesis caused due to chemotherapy in cancer patient and effective in the treatment of nausea and vomiting induced by drugs, migration and radiation sickness.
Cite this article:
Chaitali K. Gunjal, Shashikant Barhate, Manoj Bari, Shaikh Samir. Formulation Development and Evaluation of Sustained Release Rectal Suppository of Domperidone Maleate. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(1):13-2. doi: 10.52711/0975-4377.2024.00003
Cite(Electronic):
Chaitali K. Gunjal, Shashikant Barhate, Manoj Bari, Shaikh Samir. Formulation Development and Evaluation of Sustained Release Rectal Suppository of Domperidone Maleate. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(1):13-2. doi: 10.52711/0975-4377.2024.00003 Available on: https://rjpdft.com/AbstractView.aspx?PID=2024-16-1-3
REFERENCES:
1. Zawar L R and Bhandari G S, Formulation and Evaluation of Sustained Release Ondansetron Poloxamer Based Solid Suppositories, Journal of Applied Pharmaceutical Science. 2012; 2(7); 186-190.
2. E. H. Ibrahim, T. H. El-Faham, F. A. Mohammed, N. S. El-Eraky. Formulation, In-Vitro Release and Bioavailability Study of Domperidone Rectal Suppositories. International Journal of Innovations in Pharmaceutical Sciences. 2019; 8-14.
3. Gennaro A R, Remington the Science and Practice of Pharmacy, 20th edition, Philadelphia : Lippincott williams and wilkins; 884.
4. Deborah Ejiogu Chioma, Felix Sunday Yusuf. Formulation and Evaluation of Metoclopramide HCl Rectal Suppositories. Universal Journal of Pharmaceutical Research. 2019; 1-6.
5. Indian Pharmacopoeia 2018, Volume II, Government of India Ministry of Health and Family Welfare, Published by the Indian Pharmacopoeia Commission Ghaziabad, 1878-1879.
6. Badriyah Shadid Alotaibi, Fahad Pervaiz, Manal Buabeid, Akram Ashames, Khairi Mustafa Fahelelbom, Sana Siddique, Hina Shoukat, Sadia Rehman, Sobia Noreen, Ghulam Murtaza. Nanostructured Lipid Carriers Based Suppository for Enhanced Rectal Absorption of Ondansetron: In-Vitro and In-Vivo Evaluations. Arabian Journal of Chemistry, 2021; 1-14.
7. Abdelbary, G., Fahmy, R.H. Diazepam-loaded solid lipid nanoparticles: design and characterization. AAPS PharmSciTech. 2009; 10(1); 211–219.
8. Pushkar Baviskara, Anjali Bedsea, Sayyed Sadiqueb, Vikas Kundea, Shivkumar Jaiswala, Drug Delivery on Rectal Absorption: Suppositories, Int. J. Pharm. Sci. Rev. Res., 2013; 21(1): 70-76.
9. A Chatterjee, S Mohan, HM Varshney, M Jaimini, SK Sharma. Formulation and In-Vitro Characterization of Zaltoprofen Suppositories Using Bases and Different Concentration of Plasticizer. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2014; 359-370.
10. Piotr Belniak, Katarzyna S´wiazder, Michał Szumiło, Aleksandra Hyla, Ewa Poleszak. Comparison of Physicochemical Properties of Suppositories Containing Starch Hydrolysates. Saudi Pharmaceutical Journal. 2017; 365–369.
11. Loyd V. Allen. Ansel’s Pharmaceutical Dosage Form and Drug Delivery System,Eighth Edition, B. L. Publication Pvt. Ltd. 316-335
12. M. E. Alton‘s Pharmaceutics The Design and Manufacture of Medicines, Fourth Edition, 732-750.
13. L. Lackman. The Theory and Practice of Industrial Pharmacy, Special Indian Pharmacy, CBS Publishers and Distributors Pvt. Ltd. 564-588.
14. N. K. Jain. Pharmaceutical Product Development, 2 nd Edition, CBS Publication and Distributed PVP. Ltd; New Dehli, 393-395.
15. Umesh V. Bankar. Pharmaceutical Dissolution Testing, Informa Health Care, New Yourk London, Vol -49.280-285.
16. V. R. Sankar; YD Reddy; GH Reddy; GSK Reddy. Inventi Impact: Pharm Tech. 2012; 4: 275-280.
17. H. M. Varshney; A Chatterjee. Asian J Pharm Clin Res. 2012; 5(4): 235-238.
18. Muaadh A Mohamed Ali, Ashraf Mashrai and Nedham Al-dholimi. Sustained Release Suppositories of Metoclopramide HCl: Formulation and In-vitro Evaluation. Journal of Chemical and Pharmaceutical Research. 2018: 169-175.
19. G Ertan; H Y Karasulu; E Karasulu; MA Ege; T Köse; T Güneri. Drug Dev Ind Pharm. 2000; 26(7): 737- 743.
20. D Jain; S Verma; SB Shukla; AP Jain; P Jain; P Yadav. J Chem Pharm Res. 2010; 2(4): 935-978.
21. Stanislav J., Malgorzata S. and Weronika Z. Evaluation Of Paracetamol Suppositories By Pharmacopoeial Dissolution Test-Comments On Methodology, Eur. J. Pharm. Biopharm. 2001; 52: 249-254.
22. Victoria M. M., David CJ. Thermal and rheological study of lipophilic ethosuximide suppositories. Eur J Pharm Sci. 2003; 19: 123-128.
23. Deborah Ejiogu Chioma, Felix Sunday Yusuf. Formulation and Evaluation of Metoclopramide Hcl Rectal Suppositories. Universal Journal of Pharmaceutical Research. 2019; 1-6.
24. Kaewnopparat S, Kaewnopparat N. Formulation and evaluation of vaginal suppositories containing Lactobacillus. J. World Academy of Science Engineering and Technology. 2009; 55: 25-28.
25. Sunday OS. Colon-targeted drug delivery systems: design, trends and approaches. Univ J Pharm Res. 2017; 2(4): 53-57.
26. Samy EM, Hassan MA, Tous SS, Rhodes CT. Improvement of availability of allopurinol from pharmaceutical dosage forms I-suppositories. Eur J Pharm Biopharm. 2000; 49(2):119-27.
27. Vervoort L, Van den Mooter G, Augustijins P, Busson R, Toippet S, Kinget R. Pharm. Res., 14:1730–1737. 1997.
28. Jawahar N, Jayaprakash S, Maria GRNS, Nagarajan M, Dhachina Moorthi D, Jubie S, Manivannan R. Design and evaluation of sustained release suppositories of nimesulide. Indian Journal of Pharmaceutical Science. 67(5); 2005: 558- 61.
29. Basvaraj BV, Nanjundaswamy NG. Formulation and evaluation of paracetamol suppositories adapting various bases and adjuvants. Indian Drugs. 2005; 42(5): 305-8.
30. Baria A. H., Patel R. P., Suthar A. M., Parmar R. B. Formulation Development and Evaluation of Sustained Release Aceclofenac Suppository. International Journal of Pharmaceutical Sciences and Drug Research. 2009; 1(2): 71-73.
31. Saleem MA, Taher M, Sanaullah S, Najmuddin M, Ali J, Humaira S. Formulation and evaluation of tramadol hydrochloride rectal suppositories. Indian J Pharm Sci. 2008; 70(5): 640-4.
32. Nagaich U, Chaudhary V, Tonpay SD, Karki R. Design and evaluation of a metronidazole central core matrix tablet. J Adv Pharm Technol Res. 2010; 1(1): 88-96.
33. Loyd V Allen Jr. Ed, Quality Control of Suppositories, In: Suppositories, Pharmaceutical Press, London, 2008, 141-142.